Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2013/02/003429
CTRI/2013/02/003429
Completed
未知

Dyslipidemia: REsidual and Mixed Abnormalities IN spite of Statin therapy: The Dyslipidemia REMAINS Study: A multicenter, prospective, observational study of lipid profiles and treatment patterns at presentation and after 12 weeks of statin therapy among Indian adults presenting with first coronary event - REMAINS

Merck Sharp and Dohme0 sites850 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: null- DyslipidemiaHealth Condition 2: E781- Pure hyperglyceridemia

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- DyslipidemiaHealth Condition 2: E781- Pure hyperglyceridemia
Sponsor
Merck Sharp and Dohme
Enrollment
850
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Merck Sharp and Dohme

Eligibility Criteria

Inclusion Criteria

  • •Currently admitted with a confirmed diagnosis of first acute coronary event
  • •(STEMI/NSTEMI/Unstable Angina).
  • •\- Access to medical records covering the entire study period, and availability of data
  • •required for the study
  • •\- Potential to collect blood sample within 24 hours of onset for symptoms.
  • •\- Considered for initiation/maintenance/modification of statin therapy before discharge
  • •from hospital.
  • •\- Willing to comply with the study requirements.

Exclusion Criteria

  • •\- Patients who are already participating in a clinical trial or any type of other clinical study involving therapeutic intervention or otherwise failing to consent to interview
  • •\- Patients with known inherited disorder of lipoprotein metabolism
  • •\- Patients with history of hypothyroidism, nephrotic syndrome, chronic alcoholism, Cushing syndrome

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Effect of Statins on Lipid Levels Following the First Acute Coronary Event (MK-0000-204)DyslipidemiasHypercholesterolemiaHypertriglyceridemiaHigh LDL-CLow HDL-C
NCT01245738Merck Sharp & Dohme LLC635
Completed
Phase 4
Dyslipidemia management by Mustadi Ghana and lifestyle modificatio
CTRI/2017/05/008627Institute for Post Graduate Teaching and Research in Ayurveda Gujarat Ayurved University54
Completed
Not Applicable
Study in patients of increased blood cholesterolHealth Condition 1: null- patients of hypercholesterolemia eligible for statin therapy
CTRI/2016/11/007486All India Institute of Medical Sciences AIIMS
Recruiting
Not Applicable
Natural History of Uncommon Dyslipidemias, Rare Lipid Disorders and Unusual Atherosclerotic ConditionsDyslipidemiaAtherosclerosis
NCT06676046National Heart, Lung, and Blood Institute (NHLBI)1,500
Recruiting
Not Applicable
A Clinical study in patients with dyslipidemia to determine the actual status of the percentage of patients achieving the target values for the management of LDL-Cholesterol specified in the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases (2022 edition)
JPRN-UMIN000051501TOKYO CENTER CLINIC180